Ayurcann Holdings Corp.
AYURF
$0.01
-$0.01-40.91%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 6.15M | 5.60M | 5.27M | 5.36M | 6.09M |
| Total Other Revenue | 0.00 | 0.00 | -- | -- | 0.00 |
| Total Revenue | 6.15M | 5.60M | 5.27M | 5.36M | 6.09M |
| Cost of Revenue | 4.61M | 5.14M | 3.47M | 3.02M | 3.67M |
| Gross Profit | 1.54M | 454.30K | 1.80M | 2.34M | 2.42M |
| SG&A Expenses | 2.17M | 2.25M | 1.95M | 2.12M | 2.33M |
| Depreciation & Amortization | 67.60K | 20.60K | 118.60K | 151.80K | 129.70K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.85M | 7.41M | 5.54M | 5.30M | 6.13M |
| Operating Income | -695.00K | -1.81M | -269.50K | 64.20K | -38.40K |
| Income Before Tax | -801.50K | -1.88M | -391.40K | -87.00K | -180.60K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -801.50K | -1.88M | -391.40K | -87.00K | -180.60K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -801.50K | -1.88M | -391.40K | -87.00K | -180.60K |
| EBIT | -695.00K | -1.81M | -269.50K | 64.20K | -38.40K |
| EBITDA | -606.10K | -1.67M | -144.70K | 227.10K | 112.50K |
| EPS Basic | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 194.70M | 194.70M | 194.70M | 194.70M | 194.70M |
| Average Diluted Shares Outstanding | 194.70M | 194.70M | 194.70M | 194.70M | 194.70M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |